Visual outcomes of silicone oil versus gas tamponade for macular hole surgery

Seminars in Ophthalmology

Volumn 18, Issue 3, 2003, Pages 127-131

  Tafoya, Mark E ^a   Lambert, H Michael ^a   Vu, Lani ^b   Ding, Meichun ^c  

^a PLLC   (United States)

^b Paul L Foster School of Medicine   (United States)

^c RICE UNIVERSITY   (United States)

Author keywords

Macular Hole; Macular Hole Repair; Perfluoropropane (C3FB); Silicone oil; Tamponade; Vitrectomy

Indexed keywords

SILICONE OIL;

ADULT; AGED; CONFERENCE PAPER; FOLLOW UP; GAS TAMPONADE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PHOTORECEPTOR; PIGMENT DISORDER; PRIORITY JOURNAL; RETINA MACULA HOLE; RETINA PIGMENT DEGENERATION; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; SURGICAL RISK; SURGICAL TECHNIQUE; TAMPON; VISION; VISUAL ACUITY; WOUND CLOSURE; WOUND DRESSING;

AGED; FEMALE; FLUOROCARBONS; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; RETINAL PERFORATIONS; RETROSPECTIVE STUDIES; SILICONE OILS; TREATMENT OUTCOME; VISION;

EID: 1642564270     PISSN: 08820538     EISSN: None     Source Type: Journal    
DOI: 10.1076/soph.18.3.127.29808     Document Type: Conference Paper

References (12)

1. Goldbaum MH, McCuen BW, Hanneken AM et al. Silicone oil tamponade to seal macular holes without position restrictions. Ophthalmology. 1998;105:2140-2147; discussion 2147-2148.
2. Pertile G, Claes C. Silicone oil vs. gas for the treatment of full-thickness macular hole. Bull Soc Belge Ophtalmol. 1999;274:31-36.
3. Voo I, Siegner SW, Small KW. Letter to the Editor: Silicone Oil Tamponade to Seal Macular Holes. Ophthalmology. 2001;108:1516-1517.
4. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol. 1991;109:654-659.
5. Freeman WR, Azen SP, Kim JW et al. Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group [published erratum appears in Arch Ophthalmol. 1997;115:636]. Arch Ophthalmol. 1997;115:11-21.
6. Freeman WR, Azen SP, Kim JW et al. Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group [published erratum appears in Arch Ophthalmol. 1997;115:636]. Arch Ophthalmol. 1997;115:11-21.
7. Glaser BM, Michels RG, Kuppermann BD et al. Transforming growth factor-beta 2 for the treatment of full-thickness macular holes. A prospective randomized study. Ophthalmology. 1992;99:1162-1173.
8. Smiddy WE, Glaser BM, Thompson JT et al. Transforming growth factor-beta 2 significantly enhances the ability to flatten the rim of subretinal fluid surrounding macular holes. Preliminary anatomic results of multi-center prospective randomized study. Retina. 1993;13:296-301.
9. Thompson JT, Smiddy WE, Williams GA et al. Comparison of recombinant transforming growth factor beta-2 and placebo as an adjunctive agent for macular hole surgery. Ophthalmology. 1998;105:700-706.
10. Gonvers M, Hornung JP, de Courten, C. The effect of silicone oil on the rabbit retina: histologic and ultrastructural study. Arch Ophthalmol. 1982;104:1067-1072.
11. Grey RH, Cringle SJ, Constable IJ. Fluorescein angiographic findings in three patients with long-term Intravitreal liquid silicone. Br J Ophthalmol. 1989;97:238-241.
12. Chan C, Okun E. The question of ocular tolerance to Intravitreal liquid silicone: a long-term analysis. Ophthalmology. 1986;93:651-660